Do you start statins despite elevated transaminases in MASLD with advanced fibrosis and high cardiovascular risk?

Yes, the potential risk of hepatotoxicity from statins is overstated. In a large majority, statins are well-tolerated. Meanwhile, the cardiovascular risk in people with MASLD is very real. Cardiovascular disease remains the number one most common cause of death among patients with MASLD, not cirrhos...